Stock Events

Stock Events

Supernus Pharmaceuticals (SUPN) Q4 2023 Earnings

8NovConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.29

0.04

0.37

0.7

Details

Expected EPS

0.02

Actual EPS

-0.29

Surprise EPS

-0.31

Surprise Percent

+1,550%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of -0.29 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.